Department of Public Health, College of Life Sciences, Brigham Young University, Provo, Utah, USA.
J Womens Health (Larchmt). 2021 Apr;30(4):615-624. doi: 10.1089/jwh.2020.8656. Epub 2020 Oct 20.
This study assesses whether women with human immunodeficiency virus (HIV) risk behavior have higher Papanicolaou (Pap), human papillomavirus (HPV), and HIV testing, and whether the level of selected variables associated with HIV risk behavior correlate with greater testing. Association between HIV risk situations and HPV vaccination is also evaluated. A cross-sectional assessment was performed in women at age 18 years and older completing the 2018 Behavioral Risk Factor Surveillance System (BRFSS) survey. Independent variables considered and adjusted for, included age, race/ethnicity, marital status, education, annual household income, smoking status, and health care status. Prevalence of a Pap test in the past 3 years was 66.2%, of HPV test in the past 5 years was 40.2%, and of HIV test ever was 41.9%. HIV risk situations applied to 4.9% women (15.2% in ages 18-24, 7.2% in 25-44, 1.9% in 45-64, and 0.6% in 65 years and older). Adjusted odds (95% confidence interval) of a Pap, HPV, or HIV test according to HIV risk behavior status were 1.5 (1.3-1.8), 1.6 (1.4-1.8), and 2.6 (2.3-2.9), respectively. The positive association between HIV risk behavior and Pap testing depends on marital status. HIV risk behavior significantly correlates with several variables, which, in turn, correlate with testing. There was no association between HIV risk behavior and HPV vaccination. Women with HIV risk behavior are more likely to pursue Pap, HPV, and HIV testing. The significant positive associations are largest for HIV testing and smallest for Pap testing, after adjustment for the selected variables. HIV risk behavior is not associated with HPV vaccination.
本研究评估了具有人类免疫缺陷病毒 (HIV) 风险行为的女性是否进行了更高频率的巴氏涂片 (Pap)、人乳头瘤病毒 (HPV) 和 HIV 检测，以及与 HIV 风险行为相关的选定变量的水平是否与更高的检测频率相关。还评估了 HIV 风险情况与 HPV 疫苗接种之间的关联。这项横断面评估是在年龄在 18 岁及以上、完成 2018 年行为风险因素监测系统 (BRFSS) 调查的女性中进行的。考虑并调整了以下独立变量：年龄、种族/族裔、婚姻状况、教育程度、家庭年收入、吸烟状况和医疗保健状况。过去 3 年内巴氏涂片检查的患病率为 66.2%，过去 5 年内 HPV 检查的患病率为 40.2%，过去曾进行过 HIV 检查的患病率为 41.9%。4.9%的女性存在 HIV 风险情况（18-24 岁年龄组为 15.2%，25-44 岁年龄组为 7.2%，45-64 岁年龄组为 1.9%，65 岁及以上年龄组为 0.6%）。根据 HIV 风险行为状况，巴氏涂片、HPV 或 HIV 检测的调整后比值比（95%置信区间）分别为 1.5（1.3-1.8）、1.6（1.4-1.8）和 2.6（2.3-2.9）。巴氏涂片检测与 HIV 风险行为之间的正相关关系取决于婚姻状况。HIV 风险行为与多个变量显著相关，而这些变量又与检测相关。HIV 风险行为与 HPV 疫苗接种之间没有关联。
具有 HIV 风险行为的女性更有可能进行巴氏涂片、HPV 和 HIV 检测。在调整了选定变量后，调整后比值比最大的是 HIV 检测，最小的是巴氏涂片检测。HIV 风险行为与 HPV 疫苗接种无关。
